EMA approvals

Market Access

EMA’s strategy for speeding up drug approvals in the EU

The EMA is implementing major changes to accelerate drug approvals in the EU, addressing delays that affect patients and businesses alike

Market Access

FDA approval numbers soar after COVID troubles

The FDA released its overview of 2023 and the drugs it had approved during the year.

Patients

pharmaphorum with Repronovo's Jean Duvall during JPM2026

Bringing parity to infertility, with Jean Duvall

During JPM2026, pharmaphorum spoke with Jean Duvall, CEO of Repronovo, a company that’s working on new infertility treatments for men and women.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Editor's Picks